Evidence map›Paper›PMID 31849838›Full record

SynthesisFrontiers in endocrinology2019

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.

Yang Liu, Lan Ma, Xiaoling Yang, Jia Bie, Dongya Li, Chunyi Sun, Jie Zhang, Yushi Meng, Jie Lin

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Molecular Management of High-Grade Serous Ovarian Carcinoma.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang LiuDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Lan MaDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiaoling YangDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jia BieDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Dongya LiDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Chunyi SunDepartment of Gynecology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jie ZhangDepartment of Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Yushi MengDepartment of Reproductive, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jie LinDepartment of Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

associationhormone replacement therapymenopausemeta-analysisovarian cancer

Identifiers

PMID31849838
PMCPMC6902084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.